Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

PaperCitations, authors & open-access status

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 102 citations, 2018 year and closed oa status.

102
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Satomi Watanabe
Author
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
HER2/EGFR in Cancer Research
Topic
Cancer therapeutics and mechanisms
Topic
470M+ articles · free account